Silver nanoparticles modulate lipopolysaccharide-triggered Toll-like receptor signaling in immune-competent human cell lines. Issue 2 (15th January 2020)

• Record Type: Journal Article
• Authors: Gliga, Anda R.; De Loma, Jessica; Di Bucchianico, Sebastiano; Skoglund, Sara; Keshavan, Sandeep; Odnevall Wallinder, Inger; Karlsson, Hanna L.; Fadeel, Bengt
• Is Part Of: Nanoscale advances. Volume 2:Issue 2(2020)
• Page Start: 648
• Page End: 658
• Publication Date: 2020-01-15
• Subjects: 620.5
• DOI: 10.1039/c9na00721k
• Languages: English
• ISSNs: 2516-0230

Abstract

Abstract : LPS-induced TLR-signaling is suppressed following acute and long-term exposure of immune-competent cells to silver nanoparticles. Abstract : Silver (Ag) nanoparticles are commonly used in consumer products due to their antimicrobial properties. Here we studied the impact of Ag nanoparticles on immune responses by using cell lines of monocyte/macrophage and lung epithelial cell origin, respectively. Short-term experiments (24 h) showed that Ag nanoparticles reduced the lipopolysaccharide (LPS)-induced secretion of pro-inflammatory cytokines in THP-1 cells under serum-free conditions. ICP-MS analysis revealed that cellular uptake of Ag was higher under these conditions. Long-term exposure (up to 6 weeks) of BEAS-2B cells to Ag nanoparticles also suppressed pro-inflammatory cytokine production following a brief challenge with LPS. Experiments using reporter cells revealed that Ag nanoparticles as well as AgNO3 inhibited LPS-triggered Toll-like receptor (TLR) signaling. Furthermore, RNA-sequencing of BEAS-2B cells indicated that Ag nanoparticles affected TLR signaling pathways. In conclusion, Ag nanoparticles reduced the secretion of pro-inflammatory cytokines in response to LPS, likely as a result of the release of silver ions leading to an interference with TLR signaling. This could have implications for the use of Ag nanoparticles as antibacterial agents. Further in vivo studies are warranted to study this.